Tag: American research identifies cancer-fighting gut microbiome

American research identifies cancer-fighting gut microbiome

April 9, 2019

The American Cancer Society has cited metastatic melanoma as the deadliest form of skin cancer; only half of patients respond to immune checkpoint inhibitors in combination therapy, which may involve autoimmune-related side effects, limited durability of response or complete resistance to therapy. Mounting evidence supports the role of the gut microbiome in effective immune therapy, […]

Continue Reading